#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5040786	Functional	Antiproliferative activity against human KMS-11 cells assessed as reduction in cell viability incubated for 14 days by LTP assay	Homo sapiens	2	ALA5038620	cell-based format	Scientific Literature
2.	ALA5040787	Binding	Inhibition of SETD2 (unknown origin) preincubated for 30 mins followed by SAM substrate addition measured after 2 hrs by plate reader method	Homo sapiens	30	ALA5038620	single protein format	Scientific Literature
3.	ALA5040789	Binding	Inhibition of SETD2 in human A549 cells assessed as H3K36 trimethyl mark incubated for 3 days by in-cell western assay	Homo sapiens	17	ALA5038620	cell-based format	Scientific Literature
4.	ALA5040790	ADME	Stability in mouse hepatocytes assessed as intrinsic clearance measured upto 60 minutes by LC/MS/MS analysis	Mus musculus	9	ALA5038620	cell-based format	Scientific Literature
5.	ALA5040791	ADME	Stability in human hepatocytes assessed as intrinsic clearance measured upto 120 minutes by LC/MS/MS analysis	Homo sapiens	9	ALA5038620	cell-based format	Scientific Literature
6.	ALA5040792	ADME	Apparent permeability across apical to basal membrane in human Caco-2 cells measured after 2 hrs by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	cell-based format	Scientific Literature
7.	ALA5040793	ADME	Efflux ratio of apparent permeability across basolateral to apical membrane over apical to basolateral membrane in human Caco-2 cells after 2 hrs by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	cell-based format	Scientific Literature
8.	ALA5040794	ADME	Inhibition of CYP2C19 in human liver microsomes using (s)-Mephenytoin as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
9.	ALA5040795	ADME	Inhibition of CYP1A2 in human liver microsomes using Phenacetin as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
10.	ALA5040796	ADME	Inhibition of CYP2B6 in human liver microsomes using Bupropion as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
11.	ALA5040797	ADME	Inhibition of CYP2C8 in human liver microsomes using Paclitaxel as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
12.	ALA5040798	ADME	Inhibition of CYP2C9 in human liver microsomes using Tolbutamide as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
13.	ALA5040799	ADME	Inhibition of CYP2D6 in human liver microsomes using Dextromethorphan as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
14.	ALA5040800	ADME	Inhibition of CYP3A4 in human liver microsomes using Midazolam as substrate by LC-MS/MS analysis	Homo sapiens	1	ALA5038620	microsome format	Scientific Literature
15.	ALA5040801	Toxicity	Inhibition of hERG (unknown origin)	Homo sapiens	1	ALA5038620	assay format	Scientific Literature
16.	ALA5040802	ADME	Clearance in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5038620	organism-based format	Scientific Literature
17.	ALA5040803	ADME	Volume of distribution in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5038620	organism-based format	Scientific Literature
18.	ALA5040804	ADME	Terminal half life in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5038620	organism-based format	Scientific Literature
19.	ALA5040806	Functional	Antiproliferative activity against human KMS-34 cells assessed as reduction in cell viability incubated for 14 days by LTP assay	Homo sapiens	2	ALA5038620	cell-based format	Scientific Literature
20.	ALA5040807	ADME	Oral fraction absorbed in CD-1 mouse at 30 mg/kg by LC-MS/MS analysis	Mus musculus	1	ALA5038620	organism-based format	Scientific Literature